From: Adherence of physicians to evidence-based management guidelines for treating type 2 diabetes and atherosclerotic cardiovascular disease in Ajman, United Arab Emirates
Management of T2DM with cardiovascular risk
Proportion
95% CI
Prescription of SGLT2
109 (50%)
43.3–56.7
Prescription of GLP-1
47 (21.6%)
16.1–27.1
Overall adherence
122 (56%)
49.3–62.6